Effect of estrogen replacement therapy on natural killer cell activity in postmenopausal women

Maturitas

Volumn 25, Issue 3, 1996, Pages 217-222

  Albrecht, Alexander E ^a   Hartmann, Beda W ^a   Scholten, Christine ^a   Huber, Johannes C ^a   Kalinowska, Waclawa ^a   Zielinski, Christoph C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

antibody dependent cellular cytotoxicity; estrogen replacement therapy; lytic effector cell function; menopause; natural killer cell

Indexed keywords

ESTROGEN; FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ESTROGEN DEFICIENCY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; POSTMENOPAUSE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CLIMACTERIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; KILLER CELLS, NATURAL; MIDDLE AGED;

EID: 0030296167     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(96)01063-8     Document Type: Article

References (24)

1. [1] Grossmann CJ. Interactions between the gonadal steroids and the immune system. Science 1985; 227: 257-261.
2. [2] Herberman RB, Ortaldo JR. Natural killer cells: their role in defense against disease. Science 1981; 214: 24-29.
3. [3] Hanna N, Burton RC. Definitive evidence that natural killer cells inhibit experimental tumor metastasis in vivo. J Immunol 1981; 127: 1754-1758.
4. [4] Djeu JY, Heinbaugh JA, Holden HT, Herberman RB. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 1979; 122: 175-188.
5. [5] Zielinski CC, Gisinger C, Binder C, Mannhalter JW, Eibl MM. Regulation of NK cell activity by prostaglandin E2: the role of T cells. Cell Immunol 1984; 87: 65-72.
6. [6] Müller C, Schernthaner G, Kovarik J, Kalinowska W, Zielinski CC. Natural killer cell activity and antibody-dependent cellular cytotoxicity under various immunosuppressive regimens. Clin Immunol Immunopathol 1987; 44: 12-19.
7. [7] Seaman WE, Blackman MA, Gindhart TD, Roubinian JR, Loeb JM, Talal N. β-Estradiol reduces natural killer cells in mice. J Immunol 1978; 121: 2193-2198.
8. [8] Seaman WE, Gindhart TD. Effect of estrogen on natural killer cells. Arthritis Rheum 1979; 22: 1234-1240.
9. [9] Hanna N, Schneider M. Enhancement of tumor metastasis and suppression of natural killer cell activity by β-estradiol treatment. J Immunol 1983; 130: 974-980.
10. [10] Screpanti I, Santoni A, Gulino A, Herberman RB, Frati L. Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes. Cell Immunol 1987; 106: 191-202.
11. [11] Sulke AN, Jones DB, Wood PJ. Variation in natural killer activity in peripheral blood during the menstrual cycle. Br Med J 1985; 290: 884-886.
12. [12] Fergusoo MM, McDonald FG. Oestrogen as an inhibitor of human NK cell cytolysis. FEBS Lett 1985; 191: 145-148.
13. [13] Bailey JE, Schacter BZ. Mechanisms of diminished natural killer cell activity in pregnant women and neonates. J Immunol 1985; 134: 3042-3048.
14. [14] Garzetti GG, Ciavattini A, Provinciali M, Fabris N, Cignitti M, Romanini C. Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity. Obstet Gynecol 1993; 81: 665-668.
15. [15] Steinleitner A, Stanczyk FZ, Levin JH et al. Decreased in vitro production of 6-keto-prostaglandin F1α by uterine arteries from postmenopausal women. Am J Obstet Gynecol 1989; 161: 1677-1681.
16. [16] Ylikorkala O, Hirvonen E, Saure A, Viinikka L. Urinary exretion of prostacyclin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy. Prostaglandins 1990; 39: 33-37.
17. [17] Levine JH, Stanczyk FZ, Lobo RA. Estradiol stimulates the secretion of prostacyclin and thromboxane from endometrial stromal cells in culture. Fertil Steril 1992; 58: 530-536.
18. [18] Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L, Ylikorkala O. 17β-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. Clin Endocrinol Metab 1995; 80: 1832-1836.
19. [19] Whitcroft SIJ and Stevenson JC. Hormone replacement therapy: risk and benefits. Clin Endocrinol 1992; 36: 15-20.
20. [20] Hercend T and Schmidt RE. Characteristics and uses of natural killer cells. Immunol Today 1988; 9: 291-293.
21. [21] Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 76: 2421-2438.
22. [22] Nilsson N, Carlsten H. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation. Cell Immunol 1994; 158: 131-139.
23. [23] Lahita RG. Sex and age in systemic lupus erythematosus. In: Lahita RG, ed. Systemic Lupus Erythematosus. New York: Wiley, 1986; 523-539.
24. [24] Giglio T, Imro MA, Filaci G et al. Immune cell circulating subsets are affected by gonadal function. Life Sci 1994; 54: 1305-1312.